| 000 | 01771 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513194840.0 | ||
| 264 | 0 | _c19991227 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/s0005-2736(99)00143-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLomonte, B | |
| 245 | 0 | 0 |
_aTyr-->Trp-substituted peptide 115-129 of a Lys49 phospholipase A(2) expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cNov 1999 |
||
| 300 |
_a19-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCreatine Kinase _xblood |
| 650 | 0 | 4 |
_aCrotalid Venoms _xchemistry |
| 650 | 0 | 4 |
_aEndothelium _xdrug effects |
| 650 | 0 | 4 |
_aErythrocytes _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 | _aGroup II Phospholipases A2 |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aLysine _xchemistry |
| 650 | 0 | 4 |
_aMembranes _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 650 | 0 | 4 |
_aNeurotoxins _xchemistry |
| 650 | 0 | 4 |
_aPeptide Fragments _xchemistry |
| 650 | 0 | 4 |
_aPhospholipases A _xchemistry |
| 650 | 0 | 4 | _aReptilian Proteins |
| 650 | 0 | 4 |
_aTryptophan _xchemistry |
| 650 | 0 | 4 |
_aTyrosine _xchemistry |
| 700 | 1 | _aPizarro-Cerdá, J | |
| 700 | 1 | _aAngulo, Y | |
| 700 | 1 | _aGorvel, J P | |
| 700 | 1 | _aMoreno, E | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1461 _gno. 1 _gp. 19-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0005-2736(99)00143-1 _zAvailable from publisher's website |
| 999 |
_c10513048 _d10513048 |
||